Novo Nordisk
NVO
NVO
463 hedge funds and large institutions have $5.53B invested in Novo Nordisk in 2017 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 170 increasing their positions, 157 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
463
Holders Change
-19
Holders Change %
-3.94%
% of All Funds
11.54%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
49
Increased
170
Reduced
157
Closed
61
Calls
$11.3M
Puts
$19.3M
Net Calls
-$8M
Net Calls Change
+$10.8M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$191M |
| 2 |
Renaissance Technologies
New York
|
+$84.4M |
| 3 |
Millennium Management
New York
|
+$65.7M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$28.6M |
| 5 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$20.5M |
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$77.9M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$64.1M |
| 3 |
Two Sigma Advisers
New York
|
-$25.9M |
| 4 |
DAC
Dividend Assets Capital
Ridgeland,
South Carolina
|
-$23.3M |
| 5 |
JPMorgan Chase & Co
New York
|
-$22.5M |
